Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement?
Charbel Skayem, C. Cassius, Marouane Ben Kahla, C. Fiani, L. Frumholtz, M. Mrad, A. Petit, E. Zuelgaray, Martine Bagot, Jean‐David Bouaziz, T.A. Duong
Abstract
Figure 2 Number of patients with suspicious COVID-associated lesions and non-COVID lesions in the dermatologic emergencies unit.
Topics & Concepts
MedicineTeledermatologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyBetacoronavirusCoronavirus InfectionsMEDLINEVirologyTelemedicinePathologyOutbreakInfectious disease (medical specialty)Economic growthPolitical scienceDiseaseEconomicsHealth careLawDermatological and COVID-19 studiesNonmelanoma Skin Cancer StudiesCutaneous Melanoma Detection and Management